Anxiety Treatment in Sarasota: When Medication Isn’t Enough

Anxiety disorders are the most commonly diagnosed psychiatric condition in the United States, yet a significant portion of patients who try medication do not achieve full symptom relief. If you have been on an anxiolytic or antidepressant for anxiety and still find yourself unable to function the way you want to, you are not a treatment failure — you may simply need a different approach.

What Anxiety Actually Looks Like Clinically

Anxiety is not a single experience. The umbrella term covers generalized anxiety disorder, panic disorder, social anxiety disorder, and other presentations, each with its own symptom profile. Mayo Clinic describes anxiety disorders as involving persistent, excessive worry or fear that is difficult to control and that interferes with daily activities — a clinical threshold meaningfully different from ordinary stress or situational worry (Mayo Clinic).

What makes anxiety particularly resistant to standard treatment for some patients is its relationship with depression. Research confirms a strong bidirectional link between the two conditions: anxiety and depression frequently co-occur, each worsening the other, and treatments that address one without accounting for the other often fall short (American Journal of Psychiatry). At Cohen & Associates, we approach anxiety as part of a broader psychiatric picture. A patient presenting with anxious depression — significant anxiety symptoms alongside a major depressive episode — is assessed and treated differently than a patient with a primary anxiety disorder alone.

Why Medication Alone Has Limits

SSRIs and SNRIs — selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors — are typically the first medications prescribed for anxiety disorders, and they help many patients meaningfully. But they do not help everyone, and some patients experience side effects that make adherence difficult. Others achieve partial relief that plateaus before they reach the functional baseline they are looking for.

Benzodiazepines, another class of medications commonly used for acute anxiety, carry well-documented risks with long-term use. These medications can be appropriate in specific clinical contexts, but dependence and cognitive effects are real concerns that factor into our evaluation and prescribing decisions.

When medication alone is not producing adequate relief, that is clinical information — it points toward underlying mechanisms that may not be fully addressed by the pathways those medications target. Our role is to take that information seriously and look at what else might be driving the presentation.

Advanced Options We Offer for Anxiety

For patients with anxiety that has not responded adequately to standard medication, we offer several treatment options depending on the specific clinical picture.

Transcranial magnetic stimulation (TMS) — a non-invasive procedure that uses magnetic pulses to stimulate specific brain regions — is FDA-cleared for decreasing anxiety symptoms in patients who have anxious depression: major depressive disorder accompanied by significant anxiety. If your anxiety presents alongside a depressive episode, TMS may address both components simultaneously. Research supports TMS’s role in promoting neuroplasticity — the brain’s capacity to form and strengthen neural pathways involved in mood regulation — which underlies its therapeutic effects (National Center for Biotechnology Information).

Ketamine-assisted psychotherapy (KAP) is another option for patients whose anxiety has not responded to conventional treatments. Clinical evidence supports ketamine’s effectiveness in reducing anxiety symptoms that have proven resistant to standard approaches (National Library of Medicine). KAP integrates the neurological effects of ketamine with structured psychotherapy, using the window of heightened neuroplasticity that ketamine produces to support deeper therapeutic work. This option is evaluated individually — not every patient with anxiety is a KAP candidate, and a thorough evaluation is required before any recommendation is made.

Individual psychotherapy is also available at our practice through Teri Callender, LCSW, PA-C and Angelo Domingo, PsyD. For many patients, therapy is part of the answer — whether as a primary intervention or alongside medication or advanced treatment.

The Evaluation Process at Cohen & Associates

Before any treatment recommendation is made, we conduct a comprehensive psychiatric evaluation. This is where we look at your full history: what medications you have tried, at what doses, for how long, and how you responded. We also assess whether your anxiety presentation overlaps with depression, trauma, or other factors that would shape the treatment direction.

Dr. Rebecca Cohen, our interventional psychiatrist and psychopharmacologist, takes a detailed approach to medication history and selection. If you have been on multiple medications without adequate relief, she examines whether dosing, duration, drug interactions, or metabolic factors may have affected prior treatment response — including whether pharmacogenomic (genetic) testing might clarify why certain medications have not worked as expected.

No two anxiety presentations are the same. Results vary by individual, and we do not apply a standard protocol across patients. The evaluation is the starting point for building a treatment plan that actually fits your situation. For patients exploring non-medication treatment approaches for mood and anxiety conditions, that evaluation is where the conversation begins.

Addressing Fear and Access

Seeking help for anxiety when prior treatments have not worked can itself provoke anxiety. Patients sometimes arrive at our office having been told — implicitly or explicitly — that their options are limited, and that expectation shapes how willing they are to try something new. We take that seriously. Our approach is to give you an honest clinical picture of what the evidence supports for your specific presentation, without overpromising or dismissing what you have already been through.

On the practical side, we operate on a direct-care model, which means we do not bill insurance directly and do not accept insurance payments at the time of service. Patients pay by debit/credit card, check, or cash, and may be eligible for partial reimbursement from their insurance as out-of-network care. We provide invoices for that purpose on request. For patients considering TMS, insurance coverage may apply depending on your plan and clinical presentation — our team verifies coverage before treatment begins and discusses the financial picture transparently.

In-person appointments are available Monday through Thursday from 9 AM to 5 PM and Friday from 9 AM to 1 PM. Telehealth is available for appropriate aspects of care. Scheduling is done directly by phone.

FAQ

My anxiety is diagnosed as generalized anxiety disorder, not depression. Am I still a candidate for TMS?

TMS is FDA-cleared for anxiety specifically in the context of comorbid major depressive disorder — anxiety that occurs alongside a depressive episode. If your presentation is anxiety without a concurrent depressive diagnosis, TMS may not be the right fit, but a full evaluation will clarify your picture. Other treatment options, including KAP and psychotherapy, may be more applicable. Discuss your specific diagnosis with our team to explore your options.

What’s the difference between anxiety treatment at a general practitioner’s office and what you offer?

Primary care physicians can prescribe first-line medications for anxiety, but they are not typically equipped to offer advanced interventional options like TMS or KAP, conduct in-depth pharmacogenomic evaluations, or provide psychiatric psychotherapy alongside medication management. At Cohen & Associates, all of those tools are available within a single practice focused exclusively on psychiatric care.

How long does it take to see results from anxiety treatment?

It depends on the treatment. Medications typically require four to six weeks at a therapeutic dose before meaningful effects become apparent. TMS results often emerge within two to three weeks of starting the treatment course. KAP can produce noticeable changes within hours to days of treatment. Results vary by individual, and we discuss realistic timelines based on your specific treatment plan during your evaluation.

Is there a waiting list to be seen?

Contact our office directly at 941-559-8500 for current availability. We offer both in-person and telehealth appointments.

Key Takeaways

• Anxiety disorders are highly common, but a meaningful proportion of patients do not achieve full relief from standard medication alone.
• The co-occurrence of anxiety and depression is well-documented; treatment that addresses both simultaneously is often more effective than targeting either in isolation.
• TMS is FDA-cleared for anxiety symptoms in patients with comorbid major depressive disorder; KAP may be appropriate for anxiety that has not responded to conventional treatments.
• Cohen & Associates offers psychiatric evaluation, medication management, psychotherapy, TMS, and KAP within a single interventional psychiatry practice.
• Results vary by individual; a comprehensive psychiatric evaluation is the necessary first step before any advanced treatment recommendation is made.

At Cohen & Associates, a prior history of unsuccessful anxiety treatment is not a reason to stop looking — it is clinical information that shapes where we look next. Call us at 941-559-8500 or use our online contact form to schedule a new patient evaluation with our team.

References

1. Mayo Clinic. Symptoms and causes of anxiety disorders. https://www.mayoclinic.org/diseases-conditions/anxiety/symptoms-causes/syc-20350961
2. American Journal of Psychiatry. Link between anxiety and depression. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305
3. National Library of Medicine. Ketamine for anxiety. https://pubmed.ncbi.nlm.nih.gov/31339086/
4. National Center for Biotechnology Information. TMS therapy and neuroplasticity. https://pmc.ncbi.nlm.nih.gov/articles/PMC9313265/

Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Anxiety treatment, including advanced options such as TMS and ketamine-assisted psychotherapy, should only be pursued under the supervision of a licensed psychiatric provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.